Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 13/20 | 0.46 |
| ▸ | CTSB | P07858 | 2/20 | 0.36 |
| ▸ | CTSK | P43235 | 2/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.35 |
| ▸ | CCR1 | P32246 | 2/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.35 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5357125 | 0.90 | CTSS (0.44) | CTSSCTSBCTSKOPRM1OPRL1 | |
| SCHEMBL6972509 | 0.86 | CTSS (0.46) | CTSSCTSBCTSKOPRM1OPRL1 | |
| SCHEMBL6972941 | 0.84 | CTSS (0.59) | CTSSCTSBCTSKOPRM1 | |
| SCHEMBL5357132 | 0.83 | CTSS (0.53) | CTSSCTSL | |
| SCHEMBL6965440 | 0.79 | CTSS (0.54) | CTSSOPRM1OPRL1CTSL | |
| SCHEMBL5756837 | 0.77 | CTSS (0.78) | CTSS | |
| SCHEMBL5756463 | 0.77 | CTSS (0.78) | CTSS | |
| SCHEMBL6109214 | 0.77 | CTSS (0.64) | CTSSCTSBCTSL | |
| SCHEMBL14383653 | 0.77 | CTSS (0.64) | CTSSCTSBCTSL | |
| SCHEMBL5375313 | 0.76 | CTSS (0.43) | CTSSCTSBCTSKCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1218372-B1 | NOVEL HETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMA (US) | 2003-07-02 | — | — | EP | disclosed |